₹ 943.34 Cr
2.33%
S&P BSE Healthcare TRI
INF789F01679
5000.0
1000.0
500
Kamal Gada
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
UTI Healthcare Fund - Regular Plan - IDCW | 49.65 | 12.56 | 22.44 |
S&P BSE Healthcare TRI | 52.62 | 13.64 | 22.27 |
Equity
Debt
Others
An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 12.62 |
Cipla Ltd. | 6.72 |
Ajanta Pharma Ltd. | 5.85 |
Dr. Reddy's Laboratories Ltd. | 5.26 |
Apollo Hospitals Enterprise Ltd. | 4.41 |
Aurobindo Pharma Ltd. | 3.67 |
Fortis Healthcare Ltd. | 3.49 |
Krishna Institute of Medical Sciences Ltd | 3.45 |
Eris Lifesciences Ltd. | 3.29 |
Procter & Gamble Health Ltd. | 3.26 |
Sector | Holdings (%) |
---|---|
Healthcare | 97.87 |
Others | 1.41 |
Insurance | 0.61 |
Financial | 0.13 |
Scheme Name | 5Y (%) |
---|---|
UTI Healthcare Reg Income | 22.44 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 23.56 |
SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
Nippon India Pharma Fund Gr Gr | 24.41 |
UTI Healthcare Reg Gr | 22.44 |
DSP Healthcare Reg Gr | 27.19 |
Mirae Asset Healthcare Reg Gr | 25.04 |
LIC MF Healthcare Fund Reg Gr | 19.52 |